US Patent 10150962 Methods for the selection of binding proteins
Patent 10150962 was granted and assigned to Bristol-Myers Squibb on December, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+291 characters)
Article
Patent abstract
This application provides an improved screening method for the selection of target-binding proteins having desirable biophysical properties. The method combines mRNA display and yeast surface display in a way that takes advantage of the desirable attributes of both processes.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Dasa Lipovsek0
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101509620
Date of Patent
December 11, 2018
0Patent Application Number
151426510
Date Filed
April 29, 2016
0Patent Primary Examiner
Edits on 23 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10150962 Methods for the selection of binding proteins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10150962
Date of patent
December 11, 2018
Patent application number
15142651
Date Filed
April 29, 2016
Patent primary examiner
Find more entities like US Patent 10150962 Methods for the selection of binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
